Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

The potential of muscle-derived stem cells for stress urinary incontinence.

Furuta A., Jankowski RJ., Pruchnic R., Yoshimura N., Chancellor MB.

Animal Study, published in Expert Opin Biol Ther (2007) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Expert Opin Biol Ther (2007)
Country
England
Reported sample size
—
Source database
PubMed
PMID
17916041
DOI
10.1517/14712598.7.10.1483
Citations
14

Abstract (original English)

The suburethral sling procedures, such as transvaginal tape (TVT), have recently gained popularity for the treatment of stress urinary incontinence (SUI). This TVT procedure can reinforce the weakness of pelvic floor muscles but urethral sphincter deficiency remains. Adult stem cell injection therapy for SUI has recently been at the forefront of the repair of deficient urethral function. Muscle-derived stem cells and adipose-derived stem cells are regarded as candidates for the treatment of SUI because these stem cells can be easily obtained in large quantities under local anesthesia, they have the potential to undergo long-term proliferation, self-renewal and multipotent differentiation, and can serve as a vehicle of releasing neurotrophins, such as nerve growth factor, to repair the deficient urethra.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdult Stem CellsAnimalsCell DifferentiationCell ProliferationCell SurvivalHumansMesenchymal Stem Cell TransplantationMyocytes, Smooth MuscleNerve Growth Factors

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.